Suppr超能文献

分化型甲状腺癌患者5小时和24小时123I闪烁扫描的比较。

Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer.

作者信息

Shankar Lalitha K, Yamamoto Alvin J, Alavi Abass, Mandel Susan J

机构信息

Division of Nuclear Medicine, Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

出版信息

J Nucl Med. 2002 Jan;43(1):72-6.

Abstract

UNLABELLED

This study was performed to determine differences in 123I image quality at 5 and 24 h for the detection of residual thyroid or recurrent disease in patients with differentiated thyroid cancer and to evaluate which of these approaches provides the optimal yield compared with scans obtained after 131I therapy.

METHODS

The study included 99 patients (70 women, 29 men). Histopathology included 88 papillary cancers, 7 follicular cancers, and 4 Hürthle cell tumors. Each patient previously had a near-total thyroidectomy. Seventy patients were receiving initial 131I therapy, and 29 had undergone prior radioablative therapy with 131I. Whole-body images and spot views of the neck and chest were obtained with a dual-head scanner at 5 and 24 h after the oral administration of 56 MBq (1.5 mCi) Na123I. In addition, tomographic images of the neck and chest were obtained in 26 patients. The images obtained at 5 and 24 h were evaluated for the number of lesions visualized and the image quality. Seventy-four patients received radioablative therapy after this diagnostic work-up. Whole-body images were obtained on these patients 7 d after 131I therapy and were compared with the diagnostic scans.

RESULTS

Overall, images acquired 5 and 24 h after oral administration of 56 MBq (1.5 mCi) 123I were concordant in 73% of patients. For 25 patients (25%), 24-h scanning was superior by detecting additional neck foci or confirming equivocal neck foci (20 patients) and confirming equivocal pulmonary uptake (5 patients). In the subset of patients undergoing surveillance imaging after prior 131I ablation therapy with positive scans, 24-h images were superior in 66%. In 3 patients, SPECT revealed additional foci compared with planar images at 5 h. These foci were also clearly identified on the planar images obtained at 24 h. Images obtained after therapy did not identify additional sites of tumor involvement compared with those noted on 24-h images but did reveal more foci of residual thyroid tissue in 5 patients.

CONCLUSION

The diagnostic yield of planar diagnostic 123I scintigraphy at 24 h was superior to that at 5 h for lesion detection and image quality, and images obtained after 131I therapy did not reveal unknown metastatic foci.

摘要

未标注

本研究旨在确定在分化型甲状腺癌患者中,口服56MBq(1.5mCi)Na123I后5小时和24小时时,用于检测残留甲状腺或复发性疾病的123I图像质量的差异,并评估与131I治疗后获得的扫描相比,哪种方法能提供最佳的检出率。

方法

本研究纳入99例患者(70例女性,29例男性)。组织病理学检查包括88例乳头状癌、7例滤泡状癌和4例许特莱细胞肿瘤。每位患者此前均接受了近全甲状腺切除术。70例患者接受初始131I治疗,29例曾接受过131I放射性消融治疗。口服56MBq(1.5mCi)Na123I后5小时和24小时,使用双头扫描仪获取全身图像以及颈部和胸部的局部视图。此外,对26例患者获取了颈部和胸部的断层图像。评估5小时和24小时获取的图像中可见病变的数量和图像质量。74例患者在这项诊断性检查后接受了放射性消融治疗。在这些患者131I治疗7天后获取全身图像,并与诊断性扫描进行比较。

结果

总体而言,口服56MBq(1.5mCi)123I后5小时和24小时获取的图像在73%的患者中是一致的。对于25例患者(25%),24小时扫描更具优势,能够检测到额外的颈部病灶或确认可疑的颈部病灶(20例患者)以及确认可疑的肺部摄取(5例患者)。在先前接受1次131I消融治疗且扫描结果为阳性的接受监测成像的患者亚组中,24小时图像在66%的患者中更具优势。在3例患者中,单光子发射计算机断层显像(SPECT)显示与5小时的平面图像相比有额外的病灶。这些病灶在24小时获取的平面图像上也能清晰识别。与24小时图像上发现的病灶相比,治疗后获取的图像未发现额外的肿瘤累及部位,但在5例患者中发现了更多的残留甲状腺组织病灶。

结论

对于病变检测和图像质量,平面诊断性123I闪烁显像在24小时时的诊断检出率优于5小时时,且131I治疗后获取的图像未发现未知的转移病灶。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验